Clinical

Dataset Information

0

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)


ABSTRACT: This study will evaluate the safety and feasibility MRI tracking of a vaccine produced from a persons cancer cells injected intradermally once a day for 3 consecutive days. One of the daily doses will contain a chemical that can be detected by an MRI. That will be either the 1st or 3rd day of the 3 day course. On that day MRI scans will be performed 6 and 24 hours after the injection on that day. Patients may be able to receive booster doses every 1-2 months

DISEASE(S): Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Carcinoma,Colorectal Cancer,Colorectal Neoplasms,Neoplasms,Cancer

PROVIDER: 2130875 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-12-09 | GSE190001 | GEO
2023-03-20 | E-MTAB-12829 | biostudies-arrayexpress
2020-02-29 | GSE135669 | GEO
| PRJNA415943 | ENA
| PRJNA347354 | ENA
2019-05-27 | GSE106215 | GEO
2009-02-08 | E-GEOD-13975 | biostudies-arrayexpress
2009-02-01 | GSE13975 | GEO
| PRJEB36528 | ENA
2024-05-31 | GSE236360 | GEO